Skip to main content
×
×
Home

Five-year follow-up of an evidence-based prescribing intervention

  • David Meagher (a1), Ananth Pullela (a2), Marek Meisinger (a3), Niamh Geaney (a3) and Sinead O'Brien (a3)...
Abstract
Aims and Method

We studied the impact of an evidence-based multidisciplinary intervention to reduce six sub-optimal aspects of psychotropic prescribing, combined as a Prescribing Practice Quality (PPQ) score over a 5-year follow-up period in a community mental health service.

Results

Sub-optimal prescribing practices were significantly reduced after 1 year and these improvements were sustained at 5-year follow-up. The PPQ scores were significantly reduced (P<0.001) in both the overall population attending at each follow-up point as well as in the ever-present population (n=163). Use of high-dose antipsychotics and thioridazine ceased entirely; use of sedative hypnotic agents was less amenable to reduction.

Clinical Implications

Multifaceted interventions can achieve sustained improvements in prescribing practices in real-world settings.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Five-year follow-up of an evidence-based prescribing intervention
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Five-year follow-up of an evidence-based prescribing intervention
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Five-year follow-up of an evidence-based prescribing intervention
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
American Psychiatric Association (1990) Benzodiazepine Dependence, Toxicity, and Abuse: A Task Force Report. American Psychiatric Association.
Bauer, M. S. (2002) A review of quantitative studies of adherence to mental health clinical practice guideline. Harvard Review of Psychiatry, 10, 138153.
Caswell, L., Hoosen, I., Vassilas, C. A., et al (2006) Reducing hypnotic use in two older adult functional wards: an effective audit? Psychiatric Bulletin, 30, 9597.
Department of Health and Children (2002) Report of the Benzodiazepine Committee. Republic of Ireland Government Publications.
Dollman, W. B., Leblanc, V.T., Stevens, L., et al (2005) Achieving a sustained reduction in benzodiazepine use through implementation of an are awide multistrategic approach. Journal of Clinical Pharmacy and Therapeutics, 30, 425432.
Hamann, J., Ruppert, A., Auby, P., et al (2003) Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database. International Clinical Psychopharmacology, 18, 237242.
Hannon, N., Hamzah, Z., Akinpeloye, H., et al (2007) Venlafaxine–mirtazapine combination in the treatment of persistent depressive illness. Journal of Psychopharmacology, 21, 161165.
Harrington, M., Lelliott, P., Paton, C., et al (2002) The results of a multi-centre audit of the prescribing of antipsychotic drugs for in-patients in the UK. Psychiatric Bulletin, 26, 414418.
Hodgson, R. & Belgamwar, R. (2006) Off-label prescribing by psychiatrists. Psychiatric Bulletin, 30, 5557.
Karow, A. & Lambert, M. (2003) Polypharmacy in treatment with psychotropic drugs: the underestimated phenomenon. Current Opinion in Psychiatry, 16, 713718.
Lieberman, J. A. (2004) Metabolic changes associated with antipsychotic use. Journal of Clinical Psychiatry, 6 (suppl 2), 813.
Mahomed, R., Paton, C. & Lee, E. (2002) Prescribing hypnotics in a mental health trust: what consultant psychiatrists say and what they do. Pharmaceutical Journal, 268, 657659.
Meagher, D. & Moran, M. (2003) Sub-optimal prescribing in an adult community mental health service: prevalence and determinants. Psychiatric Bulletin, 27, 266270.
Meagher, D., Hannan, N. & Leonard, M. (2006) Duloxetine–mirtazapine combination in depressive illness: the case for Limerick ‘rocket fuel’. Irish Journal of Psychological Medicine, 23, 116118.
Moran, M., Raju, B. & Saunders, J., et al (2006). Achieving evidence-based prescribing practice in an adult community mental health service. Psychiatric Bulletin, 30, 5155.
Mortimer, A. M., Shepherd, C. J., Rymer, M., et al (2005) Primary care use of antipsychotic drugs: an audit and intervention study. Annals of General Psychiatry, 4, 18.
Parks, J. & Surles, R. (2004) Using best practices to manage psychiatric medications under Medicaid. Psychiatric Services, 55, 12271229.
Raju, B. & Meagher, D. (2005) Patient-controlled benzodiazepine dose reduction in a community mental health service. Irish Journal of Psychological Medicine, 22, 4245.
Reilly, J. G., Avis, S. A., Ferrier, I. N., et al (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet, 355, 10481052.
Royal College of Psychiatrists (2007) Use of Licensed Medicines for Unlicensed Applications in Psychiatric Practice (College Report CR142). Royal College of Psychiatrists.
Schneider, L. S., Dagerman, K. S. & Insel, P. (2005) Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 19341943.
Simpson, S., Beavis, D., Leddy, A., et al (2005) Naturalistic audit of NICE criteria for the use of cholinesterase inhibitors. Psychiatric Bulletin, 29, 410412.
Soumerai, S. B. (2004) Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Affairs, 23, 135146.
Spinewine, A., Swine, C., Dhillon, S., et al (2007) Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomised controlled trial. Journal of the American Geriatrics Society, 55, 658665.
Stone, J., Ohlsen, R., Taylor, D., et al (2002) Naturalistic study of the antipsychotic medication review service at the Maudsley Hospital. Psychiatric Bulletin, 26, 291294.
Tamblyn, R., Laprise, R., Hanley, J. A., et al (2001) Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA, 285, 421429.
Voshaar, R. C., Gorgels, W. J., Mol, A. J., et al (2003) Tapering off long-term benzodiazepine use with or without group cognitive–behavioural therapy: three-condition, randomised controlled trial. British Journal of Psychiatry, 182, 498504.
Wagner, A. K., Ross-Degnan, D., Gurwitz, J. H., et al (2007) Effect of New York state regulatory action on benzodiazepine prescribing and hip fracture rates. Annals of Internal Medicine, 146, 96103.
Williams, D. D. R. & McBride, A. (1999) Benzodiazepines: time for reassessment. British Journal of Psychiatry, 173, 361362.
World Health Organization (1990) Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. British Journal of Psychiatry, 156, 412.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 17 *
Loading metrics...

Abstract views

Total abstract views: 21 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 18th July 2018. This data will be updated every 24 hours.

Five-year follow-up of an evidence-based prescribing intervention

  • David Meagher (a1), Ananth Pullela (a2), Marek Meisinger (a3), Niamh Geaney (a3) and Sinead O'Brien (a3)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *